Teva Reports First Quarter 2020 Financial Results | Business Wire
DEF 14A
Teva Pharmaceutical Industries Limited - AnnualReports.com
Definitive Proxy Statement DEF 14A
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Form 10-K
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited - AnnualReports.com
DEF 14A
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Limited - AnnualReports.com
TEVA REPORTS 2017 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS FY 2017 Q4 2017 Revenues $22.4 billion $5.5 billion Cash flow f
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Teva Pharmaceutical Industries Ltd (TEVA) 10K Annual Reports & 10Q SEC Filings
Teva Pharmaceutical Industries Limited - AnnualReports.com
TEVA REPORTS 2017 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS FY 2017 Q4 2017 Revenues $22.4 billion $5.5 billion Cash flow f
Definitive Proxy Statement DEF 14A
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
